24+ years in glycobiology and the M6P pathway
24+ years in glycobiology and the M6P pathway
Glyko Consulting has spent over two decades working at the intersection of glycobiology, enzyme replacement therapy, and rare disease drug development. We work with biotech companies, foundations, and research institutions to guide programs through regulatory pathways, coordinate multi-stakeholder efforts, and build strategies that move therapies closer to patients.
We bring scientific strategy and dedicated program stewardship to every rare disease program we work on.
What We Do
Grant writing (EIC/Horizon, SBIR), study design, regulatory pathway navigation, and IND-enabling program oversight.
Full program management across multi-partner collaborations, milestone tracking, and team coordination.
Foundation engagement (ForeBatten, Lost Enzyme), patient organization strategy, and advocacy-driven development plans.
Deep Specialization
Decades of hands-on experience across the full arc of rare disease drug development, from early discovery through regulatory submission.
Trusted Relationships
We collaborate with leading foundations and rare disease organizations to accelerate therapies to patients.
Let's discuss how we can accelerate your program.
We typically respond within 24 hours.